| 标题 |
[高分]
Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2 -Positive, Non–Muscle-Invasive Bladder Cancer |
| 网址 | |
| DOI |
10.1001/jamaoncol.2026.3909
doi
|
| 其它 |
期刊:JAMA Oncology 作者:Yunkai Qie; Kaipeng Jia; Shiwang Huang; Jiazeng Zhao; Zihan Xue; et al 出版日期:2026-10-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)